Xiaobo Shi

452 total citations
20 papers, 287 citations indexed

About

Xiaobo Shi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xiaobo Shi has authored 20 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Xiaobo Shi's work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers) and Ferroptosis and cancer prognosis (5 papers). Xiaobo Shi is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers) and Ferroptosis and cancer prognosis (5 papers). Xiaobo Shi collaborates with scholars based in China, Australia and Germany. Xiaobo Shi's co-authors include Xiaozhi Zhang, Xu Zhao, Yuchen Sun, Shupei Pan, Jizhao Wang, Yuan Ma, Fengyi Qu, Xiaoxiao Liu, Jing Li and Yunfeng Hu and has published in prestigious journals such as Scientific Reports, Annals of Oncology and Cancer Letters.

In The Last Decade

Xiaobo Shi

19 papers receiving 285 citations

Peers

Xiaobo Shi
Qian Fei China
Jianbo Xiong China
Haifa Guo China
Shengda Cao China
Ye‐Ying Fang China
Zhuming Lu China
Shaolin Nie China
Zeng-Hong Li Hong Kong
Zhanwang Wang China
Haijun Wu China
Qian Fei China
Xiaobo Shi
Citations per year, relative to Xiaobo Shi Xiaobo Shi (= 1×) peers Qian Fei

Countries citing papers authored by Xiaobo Shi

Since Specialization
Citations

This map shows the geographic impact of Xiaobo Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Shi more than expected).

Fields of papers citing papers by Xiaobo Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Shi. The network helps show where Xiaobo Shi may publish in the future.

Co-authorship network of co-authors of Xiaobo Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo Shi. A scholar is included among the top collaborators of Xiaobo Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo Shi. Xiaobo Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jia, Qiang Huang, Honghong Yang, et al.. (2025). Lipid Coating of Mesoporous Silica Nanoparticles Leads to Efficient Antigen Delivery to Lymph Nodes for Cancer Vaccination. ACS Applied Bio Materials. 8(5). 4294–4302. 1 indexed citations
2.
Shi, Xiaobo, X. P. Huang, Ruijuan Zhang, et al.. (2024). N6‐methyladenosine‐mediated upregulation of LNCAROD confers radioresistance in esophageal squamous cell carcinoma through stabilizing PARP1. Clinical and Translational Medicine. 14(10). e70039–e70039. 4 indexed citations
3.
4.
Li, Jing, Yuchen Sun, Xu Zhao, et al.. (2023). Radiation induces IRAK1 expression to promote radioresistance by suppressing autophagic cell death via decreasing the ubiquitination of PRDX1 in glioma cells. Cell Death and Disease. 14(4). 259–259. 23 indexed citations
5.
6.
Shi, Xiaobo, Xiaoxiao Liu, Hao Yu, et al.. (2022). miR-4443 promotes radiation resistance of esophageal squamous cell carcinoma via targeting PTPRJ. Journal of Translational Medicine. 20(1). 626–626. 10 indexed citations
7.
Shi, Xiaobo, You Li, Shupei Pan, et al.. (2022). Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma. Scientific Reports. 12(1). 1960–1960. 15 indexed citations
8.
Zhao, Xu, Yuchen Sun, Jing Li, et al.. (2021). AEG-1 Knockdown Sensitizes Glioma Cells to Radiation Through Impairing Homologous Recombination Via Targeting RFC5. DNA and Cell Biology. 40(7). 895–905. 7 indexed citations
9.
Han, Baohui, Pan Tian, Yanqiu Zhao, et al.. (2021). 148P A phase II study of tislelizumab plus chemotherapy in EGFR mutated advanced non-squamous NSCLC patients failed to EGFR TKI therapies: First analysis. Annals of Oncology. 32. S1443–S1444. 4 indexed citations
10.
Sun, Yuchen, Jizhao Wang, Yuan Ma, et al.. (2021). Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p. Journal of Experimental & Clinical Cancer Research. 40(1). 306–306. 61 indexed citations
11.
Shi, Xiaobo, Xiaoxiao Liu, Shupei Pan, et al.. (2021). A Novel Autophagy-Related Long Non-Coding RNA Signature to Predict Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma. International Journal of General Medicine. Volume 14. 8325–8339. 16 indexed citations
12.
Liu, Xiaoxiao, Xiaobo Shi, Wei Guo, et al.. (2021). A Promising Esophageal Cancer Prognostic Signature of Ferroptosis-Related LncRNA to Predict Immune Scenery and Immunotherapy Response. International Journal of General Medicine. Volume 14. 5845–5862. 10 indexed citations
13.
Sun, Yuchen, Jing Li, Xu Zhao, et al.. (2021). SOCS6 promotes radiosensitivity and decreases cancer cell stemness in esophageal squamous cell carcinoma by regulating c-Kit ubiquitylation. Cancer Cell International. 21(1). 165–165. 18 indexed citations
14.
Liu, Xiaoxiao, Wei Guo, Xiaobo Shi, et al.. (2021). Construction and verification of prognostic nomogram for early-onset esophageal cancer. Bosnian Journal of Basic Medical Sciences. 21(6). 760–772. 14 indexed citations
15.
Shi, Xiaobo, You Li, Yuchen Sun, et al.. (2020). Genome-wide analysis of lncRNAs, miRNAs, and mRNAs forming a prognostic scoring system in esophageal squamous cell carcinoma. PeerJ. 8. e8368–e8368. 14 indexed citations
16.
Hui, Beina, Xiaobo Shi, Yang Shao, et al.. (2020). EML4-ALK, a potential therapeutic target that responds to alectinib in ovarian cancer. Japanese Journal of Clinical Oncology. 50(12). 1470–1474. 4 indexed citations
17.
Zhang, Xuanwei, Shuo Liu, Xu Zhao, et al.. (2020). Magnetic resonance imaging-based radiomic features for extrapolating infiltration levels of immune cells in lower-grade gliomas. Strahlentherapie und Onkologie. 196(10). 913–921. 21 indexed citations
18.
Sun, Yuchen, Jizhao Wang, Shupei Pan, et al.. (2018). LINC00657 played oncogenic roles in esophageal squamous cell carcinoma by targeting miR-615-3p and JunB. Biomedicine & Pharmacotherapy. 108. 316–324. 42 indexed citations
19.
Sun, Yuchen, Jizhao Wang, Shupei Pan, et al.. (2018). Nomograms To Predict Survival Rates For Esophageal Cancer Patients With Malignant Behaviors Based On ICD-0-3. Future Oncology. 15(2). 121–132. 7 indexed citations
20.
Shi, Xiaobo, Na Li, Can Liao, Qing Shu, & Fufan Zhu. (2009). Glucocorticoid or androgen for autoimmune premature ovary failure in mice.. PubMed. 34(7). 576–81. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qian Fei Breakdown of academic impact, for papers by Jianbo Xiong Breakdown of academic impact, for papers by Haifa Guo Breakdown of academic impact, for papers by Shengda Cao Breakdown of academic impact, for papers by Ye‐Ying Fang Breakdown of academic impact, for papers by Zhuming Lu Breakdown of academic impact, for papers by Shaolin Nie Breakdown of academic impact, for papers by Zeng-Hong Li Breakdown of academic impact, for papers by Zhanwang Wang Breakdown of academic impact, for papers by Haijun Wu
Rankless by CCL
2026